Market Place
Sourcing Support
Athira Pharma Presents LIFT-AD Trial Results At CTAD 2024
22 Oct 2024 //
GLOBENEWSWIRE
Athira Pharma Reports Q2 2024 Results And Pipeline Updates
01 Aug 2024 //
GLOBENEWSWIRE
Athira To Host Webinar On Fosgonimeton For Alzheimer`s Disease
12 Jun 2024 //
GLOBENEWSWIRE
Athira: Fosgonimeton Alzheimer`s Preclinical Data Published
11 Apr 2024 //
GLOBENEWSWIRE
Athira Presents Data Supporting Therapeutic Potential of Fosgonimeton
08 Mar 2024 //
GLOBENEWSWIRE
Athira Pharma Completes Enrollment of Phase 2/3 LIFT-AD Trial of Fosgonimeton
03 Jan 2024 //
GLOBENEWSWIRE
Athira Pharma Announces Encouraging Results from Phase 2 Trial of Fosgonimeton
12 Dec 2023 //
GLOBENEWSWIRE
Athira’s losing streak continues with ph. 2 failure in dementia
12 Dec 2023 //
FIERCE BIOTECH
Athira Pharma Provides Update on Plans for Ongoing LIFT-AD of Fosgonimeton
06 Sep 2022 //
GLOBENEWSWIRE
Athira Pharma Reports Second Quarter 2022 Financial Results
15 Aug 2022 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.